QNCX Chart
- 52-Week Range: $1.84 - $105.89
- Market Capitalization: $80.15M
- Short Percentage: 0%
- Target Price: $41.00
- Shares Outstanding: 36.15M
- Next Earnings: N/A
Catalysts
CategoryCatalyst
No upcoming catalysts found
News and Press Releases
- Newegg Rolls into CNE Gaming Garage Powered by AMD with Advanced Battlestations Gaming PCBusiness Wire | August 18th
- System1 to Participate in The Benchmark Company Consumer/Media/Entertainment One-on-One ConferenceBusiness Wire | August 18th
- Science 37 and Syapse Partner to Enable Faster Patient Enrollment in Oncology Clinical TrialsGlobeNewsWire | August 18th
- Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2022 Financial ResultsGlobeNewsWire | August 18th
- Reservoir Media, Inc. to Host Virtual Town Hall Event With NMPA President and CEO David IsraeliteGlobeNewsWire | August 18th
- Pear Therapeutics Lays Off 9% Of Workforce, Guides For $15 Million RevenueSeeking Alpha | August 18th
We searched over 50 sources and couldn't find any news or press releases related to Cortexyme.
Here are some articles we think you might like.
Company Info
Website: https://www.quincetx.com
Address: 601 Gateway Blvd, South San Francisco, CA, United States, 94080
Sector: N/A
Industry: N/A
Full time employees: 55
Address: 601 Gateway Blvd, South San Francisco, CA, United States, 94080
Sector: N/A
Industry: N/A
Full time employees: 55
No comments yet. Be the first.